Joe Ramos, who was hired by the Louisiana Cancer Research Center in 2022 to lead the state ... ramping up the quality of cancer research and treatment in the state. Securing an NCI designation ...

Research has shown that a potential new targeted therapy for childhood brain cancer is effective in infiltrating and killing tumor cells in preclinical models tested in mice. The novel drug CT-179 was ...

Director of Research and Innovation at the National Institute for Cancer Research and Treatment ... the immediate past Director of the Oncology Center at the University of Nigeria Teaching ...

A new nasal delivery method for amifostine could protect healthy tissue during pancreatic cancer radiation therapy, ...

Furthermore, this law created the Philippine Cancer Center (PCC), serving as ... of the 12 final themes of the PCC Research Agenda (PCC, 2024). These themes are summarized in Figure 1. 1. Cancer ...

ACS researchers compiled data from central cancer registries and from the National Center for Health Statistics ... a national cancer research and treatment organization in California.

Tuesday, Feb. 4 is World Cancer Day. The annual observation is marked to help raise awareness, educate and celebrate gains made in cancer research and treatment ... for a new center of gravity.

Pancreatic cancer is one ... and the Biotech Research & Innovation Center at the University of Copenhagen. "The past 20 years have seen virtually no progress in treatment for pancreatic cancer ...

A professor of radiation oncology, urology and medicine, and vice chair of translational research at the UCSF Helen Diller Family Comprehensive Cancer Center, Feng passed away ... therapeutic ...

better treatment, and earlier detection is certainly great news," said Rebecca Siegel, senior scientific director, surveillance research at the American Cancer Society and lead author of the report.

In fact, a 2023 study from the American Lung Association found that survival rates for lung cancer are improving, especially among historically marginalized communities of color. This is due to ...

The addition of sintilimab to neoadjuvant chemoradiotherapy achieved a 60% pathological complete response rate vs 47.3% with chemoradiotherapy alone in locally advanced ESCC.